Searchable abstracts of presentations at key conferences in endocrinology

ea0090p470 | Reproductive and Developmental Endocrinology | ECE2023

Unveiling follicular fluid oxidative stress biomarkers at polycystic ovary syndrome

Moreira Mafalda V. , Vale Fernandes Emidio , Bernardino Raquel , Alves Marco , P Monteiro Mariana

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorder of women at reproductive-age and accounts for 80% of the causes of anovulatory infertility. Despite the widely characterized reproductive, endocrine, and metabolic abnormalities, the mechanisms underlying PCOS remain unclear. Thus, it is essential to identify novel biomarkers that will allow to disclosure novel pathways involved PCOS pathophysiology, which could then be used to improve PCOS manage...

ea0029p765 | Endocrine Disruptors | ICEECE2012

Changes of hemostatic variables during cross-sex hormone treatment in transsexual people.

Sanchez-Pacheco M. , Mijares-Zamuner M. , Negueruela-Avellan G. , Segura L. , Marco P. , Pico-Alfonso A. , Moreno-Perez O.

Introduction: Cross-sex hormone treatment (CHT) in male-to-female (M2F) transsexuals affects the hemostatic balance, with the emergence of a prothrombotic state with the use of certain estrogen (oral ethinyl estradiol vs 17β estradiol). Testosterone administration to F2M transsexuals had an antithrombotic effect. In female-to-male in (F2M) transsexuals administration of testosterone seems to carry a mild antithrombotic effect.Objective: To quantify ...